卵巢附件报告和数据系统超声对卵巢肿块的诊断价值:一项两中心研究
该两中心回顾性研究用O-RADS超声分析606个中国女性卵巢肿块,鉴别良恶性的AUC为0.927,最佳截断值为>O-RADS 3,敏感度98.60%、特异度68.90%;将O-RADS 4类肿块进一步亚分类(尤其A2法)后AUC达0.942,以>O-RADS 4a为截断时敏感度93.01%、特异度82.51%。结论认为O-RADS超声诊断效能良好但特异度稍低,亚分类可提高特异度,尤其A2法。
要点
- O-RADS超声鉴别卵巢肿块良恶性的AUC为0.927(95%CI 0.903-0.946,P<.001)。
- 最佳恶性预测截断值为>O-RADS 3,敏感度98.60%、特异度68.90%。
- A2亚分类法将O-RADS 4类中含实性成分的单房和多房囊肿归为4b,其余归为4a,AUC为0.942。
核心结论
- O-RADS超声识别卵巢肿瘤的诊断效能良好,但特异度稍低;对O-RADS 4类病变进行亚分类后诊断特异度提高,尤其A2法,对中国女性有重要临床价值,值得进一步临床推广和应用。
研究设计与样本
- 两中心回顾性分析,由2名经验不同的妇科超声医师对606个中国女性卵巢肿块行O-RADS超声评估;将O-RADS 4类肿块通过3种不同方法(O-RADS A1/A2/A3)进一步亚分类为O-RADS 4a和4b。
诊断标准与关键数值
- O-RADS超声鉴别卵巢肿块良恶性的AUC为0.927(95%CI 0.903-0.946,P<.001),最佳恶性预测截断值为>O-RADS 3,敏感度98.60%、特异度68.90%。
- 3种亚分类系统的诊断效能均超过O-RADS超声(P<.05)。
- A2法将O-RADS 4类病变中含实性成分的单房和多房囊肿亚分类为O-RADS 4b,其余O-RADS 4类病变亚分类为O-RADS 4a,AUC为0.942(95%CI 0.921-0.960,P<.001)。
- A2法最佳恶性预测截断值为>O-RADS 4a,特异度82.51%、敏感度93.01%。
临床应用与阅片要点
- O-RADS超声可用于鉴别卵巢肿块良恶性,但原文指出其特异度稍低。
- 对O-RADS 4类病变按A2法亚分类(含实性成分的单房和多房囊肿归为4b,其余归为4a)可提高诊断特异度。
- A2法以>O-RADS 4a为截断时保持较高敏感度(93.01%)和较高特异度(82.51%)。
- 作者认为O-RADS 4类病变亚分类有助于更好地识别卵巢肿瘤,便于术前临床管理和诊断。
局限性
- 原文结论指出O-RADS超声诊断效能良好但特异度稍低。
- 原文结论认为值得进一步临床推广和应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to assess the diagnostic efficacy of the ovarian adnexal reporting and data system (O-RADS) and ultrasound (US) and its sub-classification system for distinguishing ovarian masses.
METHODS: O-RADS US was used for the retrospective analysis of 606 ovarian masses of Chinese from 2 medical centres by 2 gynaecologic sonographers with varying experience. The O-RADS 4 categories masses were further sub-classified into O-RADS 4a and O-RADS 4b through 3 different approaches (O-RADS A1/A2/A3).
RESULTS: The AUC of O-RADS US for differentiating benign from malignant ovarian masses was 0.927 (95% CI, 0.903-0.946, P < .001). The optimal cut-off value for predicting malignancy was >O-RADS 3, with sensitivity and specificity of 98.60% and 68.90%, respectively. The diagnostic efficacy of the 3 sub-classification systems surpassed that of O-RADS US (P < .05). Specifically, A2 approach (within O-RADS 4 lesions, unilocular and multilocular cysts with solid components were sub-classified as O-RADS 4b, whereas the remaining O-RADS 4 lesions were sub-classified as O-RADS 4a) resulted in an AUC of 0.942 (95% CI, 0.921-0.960, P < .001). The best cut-off value predicting malignancy was >O-RADS 4a, exhibiting relatively high specificity (82.51%) and maintaining a high sensitivity (93.01%).
CONCLUSION: The diagnostic efficacy of O-RADS US for identifying ovarian tumours is good, but specificity is slightly lower. This study enhanced diagnostic specificity after subclassifying O-RADS 4 lesions, especially A2 approach. It holds significant clinical value for Chinese women and merits further clinical promotion and application.
ADVANCES IN KNOWLEDGE: The sub-classification of O-RADS US allows better identifying ovarian tumours, facilitating informed preoperative clinical management and diagnosis.
引用
- Teng F, Xie H, Wei H, et al. Diagnostic value of the ovarian adnexal reporting and data system ultrasound in ovarian masses: a 2-center study. Br J Radiol. 2025. PMID: 39736086. doi:10.1093/bjr/tqae247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。